Acid-sensing ion channels (ASICs) are proton-gated cation channels that contribute to synaptic plasticity, as well as initiation of pain and neuronal death following ischemic stroke.
Introduction
Neuropeptides are a diverse class of signalling molecules that are involved in a wide variety of physiological functions, including the modulation of neurotransmission (1, 2). The neuropeptide subclass of dynorphins is best known for its modulation of the G proteincoupled opioid receptors (3) (4) (5) , through which they mediate spinal analgesia. However, it is increasingly recognised that these highly basic peptides also modulate the activity of ionotropic receptors, such as tetrameric glutamate receptors (N-methyl-D-aspartate (NMDA) subtype) and trimeric acid-sensing ion channels (ASICs) (6) (7) (8) (9) (10) . The latter interaction is of particular interest, as ASICs have emerged as mediators of both pain and stroke and thus represent potential targets in the treatment of these diseases (11) (12) (13) (14) (15) (16) (17) . In fact, big dynorphin (BigDyn) is the most potent endogenous ASIC modulator described to date. The neuropeptide was found to rescue proton-gated currents after exposure to steady-state desensitization (SSD)-inducing conditions in homomeric ASIC1a and heteromeric ASIC1a/2a and ASIC1a/2b channels in the nanomolar range and thereby promote acidosisinduced neuronal cell death in cultured neurons (10, 18) . As ASIC1a homomers and ASIC1acontaining heteromers are the most prevalent isoforms in the nervous system, this raises the possibility that inhibitors or competitors of the ASIC1a-BigDyn interaction might prove valuable therapeutics. However, despite this potential therapeutic relevance, the underlying mechanism behind this potent modulation remains elusive.
BigDyn (32 aa) and two smaller peptides, dynorphin A (DynA, 17 aa) and dynorphin B (DynB, 13 aa), are tissue-specific cleavage products of the prodynorphin precursor peptide. DynA is evolutionarily highly conserved among mammals and amphibians and displays, along with BigDyn, high affinity for opioid receptors (4) . BigDyn was reported to be ~1000-fold more potent in its modulation of ASIC1a SSD compared to DynA, while DynB did not modulate ASIC1a SSD (10) . This raises the possibility of a unique ASIC-selective pharmacophore.
Here, we set out to investigate the molecular determinants of the high potency modulation of ASIC1a by BigDyn and identify the binding site on ASIC1a. Using a combination of Note: This manuscript has not been peer-reviewed 4 electrophysiology and voltage-clamp fluorometry we demonstrate that BigDyn reduces the proton sensitivity of both activation and SSD, likely by inducing a closed resting conformation of ASIC1a that is distinct from that induced by protons and psalmotoxin-1 (PcTx1). A collection of synthetic BigDyn analogs was generated and used to identify three positively charged amino acid residues at the N-terminus of BigDyn to be primarily responsible for the modulatory effects on ASIC1a. This is complemented by chargeneutralizing amino acid substitutions in the ASIC1a extracellular domain that identify negatively charged amino acids in the acidic pocket as the binding site for BigDyn. The location of the binding site is confirmed by incorporating the non-canonical amino acid photocrosslinker azido-phenylalanine (AzF) (19, 20) in the acidic pocket of ASIC1a to covalently crosslink ASIC-BigDyn complexes using UV exposure.
Results

BigDyn affects pH dependence of mASIC1a and induces a unique closed state
First, we set out to test the ability of BigDyn and its proteolytic products ( Figure 1A) to rescue proton-gated currents after exposure to SSD-inducing conditions of wild-type (WT) mouse ASIC1a (mASIC1a) using two-electrode voltage clamp (TEVC) electrophysiology. SSD was induced using conditioning in pH 7.1, which decreased subsequent pH 5.6-induced current response to 5.7 % (95 % confidence interval (95CI): 3.8, 7.6 %) compared to that after conditioning in pH 7.4 ("control"). However, application of 1 µM BigDyn during the pH 7.1 conditioning step largely rescued pH 5.6-induced currents, resulting in 90.1 % (95CI: 77.9, 102.3 %) of the control current response. The EC50 for this current rescue was 210.6 nM (95CI: 162.6, 258.6 nM) BigDyn; Figure S1A -B). By contrast, applying DynA and DynB during conditioning did not produce significant current rescue when applied at a concentration of 1 µM (at pH 7.1) ( Figure 1B-C) , although at a concentration of 3 µM, DynA partially rescued pH 5.6-induced current ( Figure S1C ). Furthermore, co-application of 1 µM DynA or (containing the Arg18 and Lys19 that link DynA and DynB in full-length BigDyn) with DynB during conditioning did not reproduce the phenotype observed with full-length BigDyn (Figure 1B-C). Next, we sought to assess if the presence of BigDyn would affect the pH dependence of activation or SSD in WT mASIC1a. Indeed, even the presence of a subsaturating BigDyn concentration (100 nM) resulted in a significant right-shift in the pH50 activation (from 6.80 (95CI: 6.70, 6.91) to 6.66 (95CI: 6.61, 6.70) in presence of 0.1 µM BigDyn, p = 0.0172) and SSD (from 7.21 (95CI: 7.19, 7.24) to 7.15 (95CI: 7.12, 7.19), p = 0.0225) ( Figure   1D , Table S1 ).
The above results suggested that the potency of both proton activation and SSD was lowered in the presence of BigDyn, but it remained unclear if this occurred through a stabilization of the canonical resting closed state (relative to open/steady-state desensitized states) or if BigDyn induced a distinct protein conformation. To distinguish between these (B/C) Representative current traces (B) and averaged data (C) obtained by pH 5.6 application (black bar in (B)) at mASIC1a WT-expressing Xenopus laevis oocytes after preincubation in pH 7.1 (grey bar) with or without the indicated peptide or peptide combination (green bar); in (B) control currents (after pH 7.4 conditioning) are shown in grey for comparison. Asterisk in (C) indicates significant difference to control condition (p = 0.0001); n = 5-68). (D) Concentration-response curves for activation (Act.) and SSD of WT ASIC1a in the presence and (G) Averaged change in fluorescence obtained by application of PcTx1, BigDyn, DynB or pH 9.0, as shown in (F) (normalized to that obtained by application of pH 5.5) (n = 5-15). Error bars in (C), (D) and (G) represent 95CI.
Note: This manuscript has not been peer-reviewed 7 possibilities, we turned to voltage-clamp fluorometry, which allows us to directly probe ion channel conformational rearrangements using environmentally sensitive fluorescent dyes (21) . In agreement with earlier reports (22) , Alexa Fluor 488-labelled Lys105Cys mutants ( Figure 1E ) showed robust and reversible pH-induced current and fluorescence changes ( Figure 1F , Table S2 ). The upward deflection of the fluorescence signal is likely associated with channel desensitization, as the pH response curve of the fluorescence closely matches that of SSD ( Figure S2 , Table S3 ). Additionally, application of 0.3 µM tarantula toxin PcTx1, reported to stabilize the desensitized state of ASIC1a by increasing the proton sensitivity (23, 24) through binding to the acidic pocket (25, 26) , also induces an upward deflection in fluorescence without inducing current ( Figure 1F -G). By contrast, application of 1 µM BigDyn did not result in a current response, but caused a downward deflection (quenching) of the fluorescence signal, in stark contrast to the upward deflection (dequenching) observed with increased proton concentrations and PcTx1. Importantly, no fluorescence change was observed upon application of 1 µM DynB or increasing the pH to 9.0 ( Figure 1F -G, Table   S2 ), demonstrating that the BigDyn-induced conformation is dependent on a functionally active peptide and distinct from that elicited by low (or high) pH. Together, the data show that mASIC1a modulation by BigDyn is dependent on a continuous peptide sequence containing, at least parts of, both DynA and DynB and that BigDyn likely stabilizes a closed resting conformation of ASIC1a that is distinct from that induced by protons and PcTx1.
Contribution of positively charged BigDyn side chains to modulation of ASIC1a
An unusual feature of BigDyn is its high density of positive charge (net charge +9, Figure   2A ). We therefore reasoned that the interaction with ASIC1a might be driven by electrostatic forces, i.e. by binding to negatively charged side chains on ASIC1a. To investigate the contribution of individual positively charged amino acids (Arg and Lys) of BigDyn to its ability to modulate ASIC1a SSD, we generated BigDyn analogs with individual positively charged residues substituted for alanine (Ala). These ten BigDyn Ala-analogs were tested for their Note: This manuscript has not been peer-reviewed 8 ability to rescue current at WT mASIC1a when applied at 1 µM at a conditioning pH of 7.1 ( Figure 2B (Table S4 ). indicates no statistical significant difference to control condition. n = 7-48 in (C) and n = 7-9 in (D).
Note: This manuscript has not been peer-reviewed 9 By contrast, individual substitution of the remaining positive charges (Lys11, Lys13, Lys18, Arg19, Arg25, Arg26, and Lys29; Figure 2 ) or the residue situated between Arg7 and Arg9 (Ile8; Figure S3A ) showed less pronounced effects on BigDyn activity (between 29.4-76.3 % recovery; Table S4 ). This indicates that the charge of a cluster of three closely positioned Arg in the N-terminal part of BigDyn is important for the functional modulation of mASIC1a, although other properties, such as side chains size and H-bonding ability might also play a role ( Figure 2 ). This notion is confirmed by the finding that the EC50 for the modulatory effect of the Arg9Ala peptide is increased over 50-fold ( Figure 2D ). Consistent with the above, substituting the sole negative charge (Asp15) had no effect on its ability to modulate ASIC1a ( Figure S3A ). Replacing Tyr1, which has been implicated in the activity of BigDyn towards the opioid receptor (27) (28) (29) , or Trp14, resulted in a modest, but significant decrease in the ability to rescue currents ( Figure S3A ), while N-terminal truncations generally had more pronounced effects ( Figure S3B , Table S5 ).
Together, the data indicate that the BigDyn-mediated effects on ASIC1a are primarily driven by a cluster of three positively charged side chains in the N-terminal part of the neuropeptide.
Negative charges within the acidic pocket are crucial for BigDyn modulation of ASIC1a
To complement our findings with BigDyn, we next wanted to identify its binding site on ASIC1a. As we found the basic charge of BigDyn to be a crucial determinant of the interaction, we set out to mutate negatively charged side chains in the mASIC1a extracellular domain (ECD). Specifically, we focused our attention on a cavity in the ASIC1a ECD denoted the acidic pocket, which contains a high density of negatively charged residues (30) . The acidic pocket also serves as the binding site of PcTx1 (25, 26, 31) , which has been suggested to compete with BigDyn for ASIC1a modulation (10) . We introduced charge-neutralizing amino acid substitutions to individual acidic side chains (Asp to Asn and Glu to Gln substitutions) at eight positions in and around the acidic pocket ( Figure 3A ). As 10 ASIC1a mutations, especially around the acidic pocket, often lead to a change in pH sensitivity, the pH dependence of SSD for each of the mutant mASIC1a constructs was determined in order to identify the appropriate SSD conditioning pH for each mutant ( Figure S4 , Table S6 ). Next, we tested the mASIC1a variants for their sensitivity towards 1 µM BigDyn, applied during SSD conditioning. However, all tested single mutants retained significant pH 5.6-induced current rescue ( Figure 3B -C, Table S7 ), indicating that single charge-neutralizing amino acid substitutions in or near the acidic pocket alone are not enough to abolish the effect of BigDyn. Table S6 for details) with or without BigDyn (green bar) at Xenopus laevis oocytes expressing the indicated ASIC1a construct; in (B) control currents after pH 7.6 conditioning are shown in grey for comparison (n = 4-45).
(D) Concentration-response curves for BigDyn-mediated modulation of WT (black) and E238Q/D345N mutant (green) ASIC1a (n= 7-9). Error bars in (C) and (D) represent 95CI. In (C), n.s. indicates no statistical significant difference to control condition.
We therefore sought to investigate whether combined mutation of two acidic residues in the acidic pocket would abolish BigDyn modulation. Four acidic residues are found in close proximity on the upper thumb and finger domains, (Asp237, Glu238, Asp345, and Asp349; Figure 3A ) and have been suggested to interact as two carboxyl-carboxylate pairs (Asp237-Asp349 and Glu238-Asp345) (30) . We thus generated mASIC1a variants carrying a combination of two charge-neutralizing Asp to Asn and/or Glu to Gln mutations of these four residues and measured their pH dependence of steady-state desensitization ( Figure S4 and Table S6 ). The double mutant mASIC1a constructs were then tested for their sensitivity to BigDyn modulation using the same protocol as for the single mutations, except that Asp237Asn/Asp345Asn was activated at pH 4.0 in order to reach saturating currents. All four tested acidic pocket double mutants showed a drastically decreased sensitivity to 1 µM BigDyn compared to WT mASIC1a ( Figure 3B -C and Table S7 ). The biggest decrease in rescue of pH 5.6-induced currents was observed for Glu238Gln/Asp345Asn ASIC1a. For this construct, application of 1 µM BigDyn during SSD conditioning resulted in 6.8 % (95CI: 1.7, 11.8 %) current compared to pH 5.6-induced currents after pH 7.6 conditioning, which was comparable to the control response observed in absence of BigDyn ( Figure 3B -C).
Additionally, the Glu238Gln/Asp345Asn double mutant showed a roughly 50-fold increase in the EC50 for the modulatory effect of BigDyn ( Figure 3D ). As the Hill slope of ASIC1a SSD is unusually steep, we sought to confirm that the loss of the BigDyn effect observed for the double mutants was not due to a shift in pH sensitivity that rendered the channels overall unresponsive. As detailed in Figure S5A and Table S7 , this was not the case, although the Asp237Asn/Asp349Asn mutant showed a moderately reduced effect when a different conditioning pH was employed.
Next, we wanted to ascertain that the loss of BigDyn modulation is indeed specific to double charge-neutralizing mutations in or near the acidic pocket. We thus tested two additional double charge-neutralizing mutations at positions outside the acidic pocket, Asp253Asn/Glu245Gln and Glu373Gln/Glu411Gln ( Figure S5B -C). Both double mutants retained full sensitivity towards 1 µM BigDyn, indicating that the effect of double charge neutralizing mutants was specific to the acidic pocket.
In principle, it is possible that the observed loss of current rescue with the double chargeneutralizing mutations in or near the acidic pocket originates from a changed desensitization profiles. However, this is highly unlikely, given that there was no correlation between the extent of change in SSD and current rescue and mutants with WT-like or even left-shifted SSD curves showed a drastic loss of current recue (e.g. Glu238Gln/Asp345Asn and Glu238Gln/Asp349Asn). Overall, the data therefore strongly imply that the acidic pocket serves as an interaction site for BigDyn.
Photocrosslinking confirms an interaction site in the acidic pocket
To further validate the acidic pocket as the BigDyn binding site, we turned to UV-induced photocrosslinking using the photoreactive side chain of the non-canonical amino acid (ncAA) azido-phenylalanine (AzF) incorporated at different positions in ASIC1a ( Figure 4A Figure 4C , covalently crosslinked BigDyn was detected in samples containing AzF in and around the acidic pocket only when they were exposed to UV light, but not in control samples processed in absence of UV light or in UV-exposed WT hASIC1a, or when AzF was incorporated in the lower parts of the ECD, i.e. away from the acidic pocket (Tyr71 and Trp287). In summary, incorporation of the ncAA AzF in combination with UV-induced photocrosslinking confirmed that the BigDyn binding site is located at the ASIC1a acidic pocket. 
Discussion
Mechanism of action of BigDyn on ASIC1a
Despite the potential pathophysiological relevance of the ASIC-BigDyn interaction (10) is not likely to be the primary proton sensor of ASICs (37, 38) , side chains in and around the acidic pocket have been shown to modulate proton sensitivity (30, 37) . A direct binding of BigDyn to this region is therefore expected to alter proton sensing. Interestingly, our data suggest that BigDyn binding favors a resting closed state that is distinct from open and desensitized states induced by protons (or PcTx1). In other words, the BigDyn-induced conformation increases the energetic barrier to populate both open and desensitized states, consistent with the right-shift of both parameters in the presence of BigDyn ( Figure   1 ). In the case of SSD, this would result in ASIC1a remaining responsive to pH drops even during proton concentrations that would normally desensitize the channel, thus explaining the ability of BigDyn to noticeably increase ASIC1a dependent neuronal death during acidosis (10) .
As activation and desensitization both involve the collapse of the acidic pocket, bringing thumb and finger domain aspartate side chains from ~8 Å to within <3 Å of each other (39), we speculate that BigDyn binding hinders the proton-induced transitions from resting closed states to active and/or desensitized states.
Defining site of the ASIC1a-BigDyn interaction
Consistent with the hypothesis that the unusually high density of positive charge of BigDyn is crucial for its functional effects, we find that charge-neutralizing mutations of basic amino acids reduce the ability of BigDyn to rescue ASIC1a proton-gated currents after exposure to steady-state desensitization (SSD)-inducing conditions. This effect was particularly pronounced for mutations in a cluster of three Arg (Arg6, Arg7 and Arg9) in the N-terminal part of the peptide, while no effect was observed when mutating the only non-charged side chain in between amino acids 6 and 9 (Ile8). This is in agreement with the finding that DynA (representing the N-terminal part of BigDyn), but not DynB (representing the C-terminal part of BigDyn) can have modulatory effects on ASICs (10, 40) ( Figure S1C ). However, it is worth noting that functional effects were also reduced when mutating Lys11, Arg19, Arg26 and Tyr1, albeit to a lesser extent (Figure 2 and S3A) . These data suggest that the interaction of BigDyn with ASIC1a is not solely driven by charge at Arg6, Arg7 and Arg9, but also mediated by other, mostly basic amino acids throughout the peptide sequence. This notion is further supported by data from our N-terminal truncation screen and complemented by the finding that AzF incorporated at positions along the entire length of the cleft formed by the acidic pocket enabled to covalently crosslink to BigDyn. Together, this argues for an extended interaction surface on ASIC1a, likely extending from the peripheral thumb domain around the α5 helix and into the acidic pocket. While the location of the BigDyn binding site is distinct from that suggested for RFamide neuropeptides on ASICs (41, 42) , it does overlap with the binding site for PcTx1 (10, 25, 26, 31) . This is consistent with the finding that RFamides do not functionally compete with BigDyn or PcTx1 (10, 43) . Interestingly, both PcTx1 and BigDyn bind to the acidic pocket through extensive charge-charge interactions, and additional contributions are made by aromatic amino acids (i.e. Trp7 and Trp24 in PcTx1 (31) and Tyr1 in BigDyn). However, the binding mode is likely to differ substantially between the two peptides, as PcTx1 adopts a rigid fold, while BigDyn is likely unstructured in aqueous solution (44, 45) . Indeed, the two peptides have opposite modulatory effects on ASIC1a:
while PcTx1 interacts with and stabilizes the desensitized state (24) , our data suggest that BigDyn stabilizes a closed/resting state of ASIC1a (see above).
Possible biological implications
Intriguingly, both ASIC1a and dynorphins have been shown to exhibit overlapping expression patterns (e.g. amygdala, hippocampus) and to contribute to a similar array of both physiological (learning, memory) and pathophysiological (pain, nociception, addiction) processes (4, 5, 11, 12, (46) (47) (48) (49) (50) (51) (52) . Among the dynorphins tested here, BigDyn is the most potent at ASIC1a and has also been shown to greatly enhance acidosis-induced cell death in cortical neurons (10) . The potential relevance of this finding is underscored by the fact that under pathophysiological conditions, the BigDyn levels will be sufficient to modulate ASIC activity in vivo (up to low micromolar range) (4, 5, 8, 10, 53, 54) . By contrast, the modulatory effects under physiological BigDyn concentrations (1-10 nM) would likely be small, although others have reported a higher sensitivity of ASIC1a towards BigDyn (10) . Together, this highlights the potential of the ASIC-BigDyn interaction site as a drug target. Given that BigDyn and PcTx1 share a common binding site, this notion is supported by the finding that PcTx1 or PcTx1-like peptides show promise in limiting neuronal death in stroke models (14, 15) . While the ASIC-BigDyn interaction per se increases neuronal death, a therapeutic option might in the future emerge from building upon the scaffold of modified peptides with reduced activity (similar to some presented in this study) that could, if refined, work as silent modulators to prevent the ASIC-BigDyn interaction. Recent work on PcTx1 has shown that peptides targeting the ASIC acidic pocket can display significant functional plasticity.
For example, altered pH or mutations within the toxin (Arg27Ala or Phe30Ala) can effectively convert PcTx1 into a potentiator) (31, 55) . Similarly, and depending on cellular context and presence of co-factors, DynA can act as both an inhibitor and potentiator of glutamate receptors (4) . It will thus be intriguing to see if this functional dichotomy is also possible to achieve for BigDyn in order to unlock its potential as an ASIC-targeting therapeutic lead.
Methods
Molecular biology
The complementary DNA (cDNA) encoding mouse ASIC1a (mASIC1a) was used as previously described (56), while the human ASIC1a (hASIC1a) cDNA was kindly provided by Dr Stephan Kellenberger. Plasmids containing AzF RS and tRNA were gifts from Dr Thomas P. Sakmar (32) . The dominant negative eukaryotic release factor (DN-eRF) was a gift from Dr William Zagotta (57) .
Site-directed mutagenesis was performed using PfuUltraII Fusion polymerase (Agilent) and custom DNA mutagenesis primers (Eurofins Genomics). All sequences were confirmed by sequencing of the full coding frame (Eurofins Genomics). For hASIC1a constructs, a Cterminal 1D4-tag was added for protein purification and Western blot detection and two silent mutations were inserted at V10 and L30 to reduce the risk of potential reinitiation (58) . cDNAs were linearized with EcoRI (mASIC1a) or HindIII-HF (hASIC1a, both New England Biolabs) and capped cRNA was transcribed with the Ambion mMESSAGE mMACHINE SP6 (mASIC1a) kit (Thermo Fisher Scientific).
Electrophysiological recordings and data analysis
Oocytes were surgically removed from adult female Xenopus laevis and prepared as previously described (56) . Oocytes were injected with 0.1 to 10 ng cRNA of mouse ASIC1a (mASIC1a) or hASIC1a mRNA into the cytosol (volumes between 9 and 50 nL). Typically, higher amounts of mutant mASIC1a constructs were injected compared WT mASIC1a. 1-4 days after injection, oocytes were transferred to a recording chamber (59) applications of pH 5.6. The resting period between pH 5.6 applications was 2 min. In order to ensure that the observed current desensitization was not due to general current rundown, a final application of pH 5.6 was performed after a 2 min resting period at a resting pH that resulting in saturating current responses. Traces were used for further analysis only if the final pH 5.6 application resulted in currents that were ≥ 80 % of the same resting pH prior to the SSD protocol.
The ability of dynorphin peptides to rescue ASIC1a proton-gated currents after exposure to SSD-inducing conditions was examined at a resting pH of 7.6 (unless stated otherwise).
Channel activation was achieved by application of pH 5.6 (except for D237N/D345N and E373Q/E411Q construct which required pH 4.0 for full activation) for 20 s. The oocytes were left to recover for 1 min in pH 7.6 solution. Hereafter, the oocyte was perfused for 2 min with SSD-inducing pH (determined specifically for each individual ASIC1a construct/mutant) prior to a 20 s application of pH 5.6. Dynorphin peptides were applied during the 2 min of SSD conditioning. The channels were checked for ability to recover (cutoff at ≥80 % recovery) after 3 min of pH 7.6 solution by an additional 20 s application pH 5.6. The effect of the dynorphin peptides was determined by normalizing the current post-peptide application to the mean of the two currents elicited without SSD conditioning pH.
Voltage-clamp fluorometry
For voltage-clamp fluorometry (VCF), 5-20 ng of mASIC1a K105C mRNA were injected into oocytes which were then incubated for 2-7 days. On the day of the recording, oocytes were labeled by incubating them for 30 min with 10 μM AlexaFlour 488 C5-maleimide (Thermo Fisher Scientific) in OR2 solution at room temperature, subsequently washed twice with OR2, and stored in the dark until further use. The oocytes were placed in the custom-built recording chamber above a water immersion objective of an inverse microscope (IX73 with LUMPlanFL N 40x, Olympus), with the animal pole facing the excitation source. An Olympus TH4-200 halogen lamp using a standard GFP filter-set (Olympus) was used to excite the fluorophore while the emission was detected using a P25PC-19 photomultiplier tube (Sens-Tech) and photon-to-voltage converter (IonOptix), via the microscope side port. Current and fluorescence signals were acquired, filtered, digitized and digitally filtered as described for the other electrophysiology recordings.
For VCF measurements in Fig 1F-G, 0 .05% BSA was added to all solutions (composition as described above). Channels were activated for 20 s using pH 5.5 buffer, washed for 1 min with pH 7.6 buffer, exposed for 2 min to 0.3 µM PcTx, 1 µM BigDyn or DynB at pH 7.6 respectively, followed by a 2 min washout at pH 7.6 and a subsequent 20 s exposure to pH 5.5. For the pH response curve in SI Figure S2 , oocytes were exposed for 20 s to pH 6.0, washed for 1 min at pH 7.6, exposed for 1-2 min (until fluorescent signal reached a plateau) with preconditioning pH 7.2, followed directly by exposure to pH 6.0. After a 1min washout at 7.6 this protocol was consecutively repeated using decreasing preconditioning pHs (7.1, 7.0, 6.8, 6.6), in the end the response to pH 6.4 was measured. All signals were reported relative to deflections at pH 6.0 for the pH-response curve in SI Figure S2 and relative to deflections at pH 5.5 for experiments in Figure 1F data shown as mean ± 95CI; n = 9. (C) Averaged data obtained by pH 5.6 application at mASIC1a WT after preincubation in pH 7.1 (grey bar) with or without the indicated peptide (green bar); each dot represents an individual oocyte and bars represent mean + 95CI.
Asterisk in (C) indicates significant difference to control condition (p = 0.0001) n = 4-68. See Table S6 for further details. Table S5 : Effect of different dynorphins and truncated BigDyn analogs on mASIC1a SSD. Mean rescue of current after exposure to SSD-inducing pH at WT mASIC1a, with 95CI stated in parentheses; the effect of the peptides compared to control was analyzed using a oneway ANOVA with a Dunnett's multiple comparisons test, *, p < 0.05; ** p < 0.01; ***, p < 0.001; **** p < 0.0001; n.s = not significant. n = number of experiments. Table S6 : Characterization pH dependence of SSD of WT and mutant mASIC1a and WT hASIC1a. pH50 and Hill coefficients for steady-state desensitization (obtained with indicated activating pH), including resulting pH to induce SSD (SSD pH). 95CI stated in parentheses; n = number of experiments, E373Q/E411Q was characterized on a single batch of oocytes.
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